High blood carbon dioxide variability and adverse outcomes in neonatal hypoxic ischemic encephalopathy

Gregory Hansen, Nasser Al Shafouri, Michael Narvey, Jeff K. Vallance, Ganesh Srinivasan

Research output: Contribution to journalJournal Articlepeer-review

13 Citations (Scopus)

Abstract

Objective: Hypocarbia during the first 12 h of life is associated with mortality and disability in neonatal hypoxic ischemic encephalopathy (HIE). Notable variation in arterial carbon dioxide tension (PaCO2) during the first 4 d of life is related to severe intraventricular hemorrhages in preterm infants. We examined the association between PaCO2 during 72 h of whole-body therapeutic hypothermia for neonatal HIE and 2-year neurodevelopmental outcomes.Methods: A retrospective review of 23 term neonates treated with whole-body hypothermia documented clinical, demographic and arterial blood gas data. Comparisons were made across good and severe neurodevelopmental outcome groups at 2 years of age.Results: Severe neurodevelopmental outcomes were documented in 8 of 23 toddlers. There were no significant differences between outcome groups with regard to the number of patients with hypocarbic means or measurements. There were also no significant differences with mean PaCO2, PaO2, pH, time-weighted cumulative hypocarbia, and PaCO2 range. The severe neurodevelopmental outcomes group had a significantly higher mean PaCO2 standard deviation (p = 0.04; 95% CI, -5.46 to -0.39).Conclusion: Severe neurodevelopmental outcomes were significantly associated with high PaCO2 variability over 72 h in whole-body-cooled HIE neonates. Mitigating these fluctuations may be a potential management strategy.

Original languageEnglish
Pages (from-to)680-683
Number of pages4
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume29
Issue number4
DOIs
Publication statusPublished - 16 Feb. 2016

Keywords

  • Asphyxia
  • blood gas analysis
  • hypothermia
  • infant
  • treatment outcomes

Fingerprint

Dive into the research topics of 'High blood carbon dioxide variability and adverse outcomes in neonatal hypoxic ischemic encephalopathy'. Together they form a unique fingerprint.

Cite this